Super-enhancer-associated lncRNA HDAC11-AS1 aggravates hepatocellular carcinoma progression by modulating HDAC11 and NUP210 expression via promoting super-enhancer activity
Cellular Oncology · 13.05.2026 · 49 (4)
DOI: 10.1007/s13402-026-01200-x ↗Kurz gefasst
Fachartikel in der Zeitschrift Cellular Oncology, online erschienen am 13.05.2026. Verfasst von Weidong Ye und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Shanghai Medical College, Fudan University Fudan University Shanghai Cancer Center, Shanghai, China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, RNA, Long Noncoding, Super Enhancers. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oncology, Shanghai Medical College, Fudan University Fudan University Shanghai Cancer Center, Shanghai, China.
- State Key Laboratory of Systems Medicine for Cancer, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
- Department of Integrative Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.
- Department of Minimally Invasive Therapy Center, Fudan University Shanghai Cancer Center, Shanghai, China.
- Department of Liver Surgery, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
- Department of Liver Surgery, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. czan0907@126.com.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Ye, W., Xiao, J., Li, J., Yang, C., Li, C., Xi, Z., & Cheng, Z. (2026). Super-enhancer-associated lncRNA HDAC11-AS1 aggravates hepatocellular carcinoma progression by modulating HDAC11 and NUP210 expression via promoting super-enhancer activity. Cellular Oncology, 49(4). https://doi.org/10.1007/s13402-026-01200-x
Vancouver
Ye W, Xiao J, Li J, Yang C, Li C, Xi Z, et al. Super-enhancer-associated lncRNA HDAC11-AS1 aggravates hepatocellular carcinoma progression by modulating HDAC11 and NUP210 expression via promoting super-enhancer activity. Cellular Oncology. 2026;49(4). doi:10.1007/s13402-026-01200-x
BibTeX
@article{Ye2026,
author = {Ye, Weidong and Xiao, Junyuan and Li, Jiaxin and Yang, Cheng and Li, Chunlai and Xi, Zhifeng and Cheng, Zhuoan},
title = {Super-enhancer-associated lncRNA HDAC11-AS1 aggravates hepatocellular carcinoma progression by modulating HDAC11 and NUP210 expression via promoting super-enhancer activity},
journal = {Cellular Oncology},
year = {2026},
volume = {49},
number = {4},
doi = {10.1007/s13402-026-01200-x}
}
EUVIMED